维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

11篇 您的检索式：作者名="Hellmann MD"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers:proposal for the use of major pathological response as a surrogate endpoint显示文摘	Hellmann MD Chaft JE William WN Jr	2014	Lancet Oncol2014，15，1：	1
	2	Mutational land- scape determines sensitivity to PD-1 blockade in non-small cell lung cancer显示文摘	Rizvi NA Hellmann MD Snyder A	2015	Science2015，348，6230：	1
	3	Treatment of primary mediastinal B-cell lymphoma with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone is associated with a high rate of primary refractory disease显示文摘	Soumerai JD Hellmann MD Feng Y	2014	Leuk Lymphoma2014，55，3：	1
	4	Pathological response after neoadjuvant chemotherapy in resectable non small cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint显示文摘	Hellmann MD Chaft JE William WN	2014	Lancet Oncol2014，15，：	1
	5	Risk of hemoptysis in patients with resected squamous cell and other high-risk lung cancers treated with adjuvant bevacizumab 显示文摘	Hellmann MD Chaft JE Rusch V	2013	Cancer Chemoth Pharm2013，72，2：	1
	6	Mutational land?scape determines sensitivity to PD-l blockade in non-small cell lung cancer显示文摘	Rizvi NA Hellmann MD Snyder A etal	2015	Science2015，348，：	1
	7	First-line mono- therapy with nivolumab ( NIVO; anti-programmed death-1 ) in advanced non-small cell lung cancer ( NSCLC ) : Safety, efficacy and correlation of outcomes with PD-1 ligand ( PD-L1 ) expression显示文摘	Gettinger N Hellmann MD Shepherd FA	2015	J Clin Oncol2015，，：	1
	8	Poor response to erlotinib in patients with tumors containing baseline EGFR T790M mutations found by routine clinical molec- ular testing显示文摘	Yu HA Arcila ME Hellmann MD	2014	Ann Oncol2014，25，2：	1
	9	Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint显示文摘	Hellmann MD Chaft JE William WN Jr	2014	Lancet Oncol2014，15，1：	1
	10	Pathological response after neoadjuvant chemotherapy in resectable non- small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint 显示文摘	Hellmann MD Chaft JE William WN Jr	2014	Lancet Oncol2014，15，1：	1
	11	Poor response to erlotinib in patients with tumors containing baseline EGFR T790M mutations found by routine clinical molecular testing 显示文摘	Yu HA Arcila ME Hellmann MD	2014	Ann Oncol2014，25，2：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费